281 related articles for article (PubMed ID: 20603625)
1. Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.
Domschke K; Reif A; Weber H; Richter J; Hohoff C; Ohrmann P; Pedersen A; Bauer J; Suslow T; Kugel H; Heindel W; Baumann C; Klauke B; Jacob C; Maier W; Fritze J; Bandelow B; Krakowitzky P; Rothermundt M; Erhardt A; Binder EB; Holsboer F; Gerlach AL; Kircher T; Lang T; Alpers GW; Ströhle A; Fehm L; Gloster AT; Wittchen HU; Arolt V; Pauli P; Hamm A; Deckert J
Mol Psychiatry; 2011 Sep; 16(9):938-48. PubMed ID: 20603625
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.
Okamura N; Hashimoto K; Iyo M; Shimizu E; Dempfle A; Friedel S; Reinscheid RK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1444-8. PubMed ID: 17669576
[TBL] [Abstract][Full Text] [Related]
3. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder.
Domschke K; Ohrmann P; Braun M; Suslow T; Bauer J; Hohoff C; Kersting A; Engelien A; Arolt V; Heindel W; Deckert J; Kugel H
Psychiatry Res; 2008 May; 163(1):13-20. PubMed ID: 18440204
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder.
Richter J; Hamm AO; Pané-Farré CA; Gerlach AL; Gloster AT; Wittchen HU; Lang T; Alpers GW; Helbig-Lang S; Deckert J; Fydrich T; Fehm L; Ströhle A; Kircher T; Arolt V
Biol Psychiatry; 2012 Sep; 72(6):512-20. PubMed ID: 22621998
[TBL] [Abstract][Full Text] [Related]
5. Functional magnetic resonance imaging correlates of emotional word encoding and recognition in depression and anxiety disorders.
van Tol MJ; Demenescu LR; van der Wee NJ; Kortekaas R; Marjan M A N; Boer JA; Renken RJ; van Buchem MA; Zitman FG; Aleman A; Veltman DJ
Biol Psychiatry; 2012 Apr; 71(7):593-602. PubMed ID: 22206877
[TBL] [Abstract][Full Text] [Related]
6. Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls.
Gechter J; Liebscher C; Geiger MJ; Wittmann A; Schlagenhauf F; Lueken U; Wittchen HU; Pfleiderer B; Arolt V; Kircher T; Straube B; Deckert J; Weber H; Herrmann MJ; Reif A; Domschke K; Ströhle A
Neuroimage Clin; 2019; 24():102029. PubMed ID: 31734525
[TBL] [Abstract][Full Text] [Related]
7. Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia.
Ridderbusch IC; Richter J; Yang Y; Hoefler M; Weber H; Reif A; Hamm A; Pané-Farré CA; Gerlach AL; Stroehle A; Pfleiderer B; Arolt V; Wittchen HU; Gloster A; Lang T; Helbig-Lang S; Fehm L; Pauli P; Kircher T; Lueken U; Straube B
Eur Neuropsychopharmacol; 2019 Oct; 29(10):1138-1151. PubMed ID: 31444036
[TBL] [Abstract][Full Text] [Related]
8. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks.
Thoeringer CK; Binder EB; Salyakina D; Erhardt A; Ising M; Unschuld PG; Kern N; Lucae S; Brueckl TM; Mueller MB; Fuchs B; Puetz B; Lieb R; Uhr M; Holsboer F; Mueller-Myhsok B; Keck ME
J Psychiatr Res; 2007 Oct; 41(7):579-84. PubMed ID: 16904689
[TBL] [Abstract][Full Text] [Related]
9. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide S receptor gene: fear-specific modulations of prefrontal activation.
Tupak SV; Reif A; Pauli P; Dresler T; Herrmann MJ; Domschke K; Jochum C; Haas E; Baumann C; Weber H; Fallgatter AJ; Deckert J; Ehlis AC
Neuroimage; 2013 Feb; 66():353-60. PubMed ID: 23103692
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders.
Erhardt A; Lucae S; Unschuld PG; Ising M; Kern N; Salyakina D; Lieb R; Uhr M; Binder EB; Keck ME; Müller-Myhsok B; Holsboer F
J Affect Disord; 2007 Aug; 101(1-3):159-68. PubMed ID: 17197037
[TBL] [Abstract][Full Text] [Related]
12. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.
Kircher T; Arolt V; Jansen A; Pyka M; Reinhardt I; Kellermann T; Konrad C; Lueken U; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Wittchen HU; Straube B
Biol Psychiatry; 2013 Jan; 73(1):93-101. PubMed ID: 22921454
[TBL] [Abstract][Full Text] [Related]
13. Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene.
Annerbrink K; Westberg L; Olsson M; Andersch S; Sjödin I; Holm G; Allgulander C; Eriksson E
Psychiatr Genet; 2011 Apr; 21(2):85-9. PubMed ID: 21666548
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide S receptor (NPSR1) gene variation modulates response inhibition and error monitoring.
Beste C; Konrad C; Uhlmann C; Arolt V; Zwanzger P; Domschke K
Neuroimage; 2013 May; 71():1-9. PubMed ID: 23319044
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli.
Dannlowski U; Kugel H; Franke F; Stuhrmann A; Hohoff C; Zwanzger P; Lenzen T; Grotegerd D; Suslow T; Arolt V; Heindel W; Domschke K
Neuropsychopharmacology; 2011 Aug; 36(9):1879-85. PubMed ID: 21525857
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
[TBL] [Abstract][Full Text] [Related]
17. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
[TBL] [Abstract][Full Text] [Related]
18. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
Bandelow B; Saleh K; Pauls J; Domschke K; Wedekind D; Falkai P
World J Biol Psychiatry; 2010 Feb; 11(1):66-70. PubMed ID: 20146651
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder.
Politi P; Minoretti P; Falcone C; Martinelli V; Emanuele E
Neurosci Lett; 2006 Mar; 396(2):163-6. PubMed ID: 16352396
[TBL] [Abstract][Full Text] [Related]
20. Decreased gray matter volume of the medial orbitofrontal cortex in panic disorder with agoraphobia: a preliminary study.
Na KS; Ham BJ; Lee MS; Kim L; Kim YK; Lee HJ; Yoon HK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():195-200. PubMed ID: 23628432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
